Roivassepp Investment OÜ

Active Registry code 16806432 OÜ Tallinn Registered 28 Aug 2023
Compare

Roivassepp Investment OÜ is a OÜ based in Tallinn, registry code 16806432, status: active. Main activity: Medical specialists activities. Its annual report for 2025 shows revenue of €41 368 and 0 employees.

Turnover
—
State taxes
2 727 €
Labour taxes
2 338 €
Employees
2
±0 vs Q2 2026

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Human health activities · EMTAK 86

  • Labour taxes per employee 1 169 €
    industry median 2 177 € · companies in the industry: 1 696
  • Revenue · 2025 41 368 €
    industry median 20 811 € · companies in the industry: 3 373
  • Net profit margin · 2025 87.1 %
    industry median 8.3 % · companies in the industry: 2 759

Taxes and turnover

Q2 2026 – Q3 2026
Labour taxes per employee, € Q3 2026: 1 169 € · industry median 2 177 € · above 28% of the industry
05001 0001 5002 0002 500Q2 2026 Company: — Industry median: 2 159 €Q2·26Q3 2026 Company: 1 169 € Industry median: 2 177 €Q3·2605001 0001 5002 0002 500Q2 2026 Company: — Industry median: 2 159 €Q3 2026 Company: 1 169 € Industry median: 2 177 €Q3·26
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q3 2026: 2 · +0.0% vs Q2 2026
0.00.51.01.52.0Q2 2026 Company: 2Q2·26Q3 2026 Company: 2Q3·260.00.51.01.52.0Q2 2026 Company: 2Q3 2026 Company: 2Q3·26
State taxes, € Q3 2026: 2 727 €
01 0002 0003 000Q2 2026 Company: —Q2·26Q3 2026 Company: 2 727 €Q3·2601 0002 0003 000Q2 2026 Company: —Q3 2026 Company: 2 727 €Q3·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 — 2 727 2 338 2
Q2 2026 — — — 2
Labour taxes per employee per month
390 €

Q3 2026 · calculated from EMTA data

Financials by year

2024 – 2025
Revenue, € 2025: 41 368 € · +6.6% vs 2024 · industry median 20 811 € · above 61% of the industry
010 00020 00030 00040 00050 0002024 Company: 38 804 € Industry median: 20 000 €20242025 Company: 41 368 € Industry median: 20 811 €2025010 00020 00030 00040 00050 0002024 Company: 38 804 € Industry median: 20 000 €2025 Company: 41 368 € Industry median: 20 811 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 36 042 € · +15.1% vs 2024 · industry median 1 071 € · above 82% of the industry
010 00020 00030 00040 0002024 Company: 31 321 € Industry median: 1 621 €20242025 Company: 36 042 € Industry median: 1 071 €2025010 00020 00030 00040 0002024 Company: 31 321 € Industry median: 1 621 €2025 Company: 36 042 € Industry median: 1 071 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 87.1 % · +6.4 pp vs the year before · industry median 8.3 % · above 98% of the industry
0204060801002024 Company: 80.7 % Industry median: 10.7 %20242025 Company: 87.1 % Industry median: 8.3 %20250204060801002024 Company: 80.7 % Industry median: 10.7 %2025 Company: 87.1 % Industry median: 8.3 %2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2025: 113 433 € · +93.1% vs 2024
02550751001252024 Company: 58 751 €20242025 Company: 113 433 €202502550751001252024 Company: 58 751 €2025 Company: 113 433 €2025
Equity, € 2025: 69 863 € · +106.6% vs 2024
020 00040 00060 00080 0002024 Company: 33 821 €20242025 Company: 69 863 €2025020 00040 00060 00080 0002024 Company: 33 821 €2025 Company: 69 863 €2025
Employees 2025: 0 · industry median 2 · above 2% of the industry
0.00.51.01.52.02024 Company: 0 Industry median: 220242025 Company: 0 Industry median: 220250.00.51.01.52.02024 Company: 0 Industry median: 22025 Company: 0 Industry median: 22025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 41 368 36 042 0 113 433 69 863 0
2024 38 804 31 321 0 58 751 33 821 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
87.1 %
Net profit / revenue
Return on equity (ROE)
51.6 %
Net profit / equity
Return on assets (ROA)
31.8 %
Net profit / assets
Equity ratio
61.6 %
Equity / assets
Debt ratio
38.4 %
Liabilities / assets
Current ratio
1.12
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 30 Jun 2026 Company’s own e-Äriregister
2024 28 Aug 2023 – 31 Dec 2024 30 Jun 2025 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 86221Medical specialists activities Main

Rulings 5

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 50235795 / 5
27 Dec 2023
 Amendment entry In force
27 Dec 2023
 PDF
Ä 50235795 / 4
6 Dec 2023
 Amendment entry In force
6 Dec 2023
 PDF
Ä 50235795 / 3
14 Sep 2023
 Amendment entry In force
14 Sep 2023
 PDF
Ä 50235795 / 2
2 Sep 2023
 Amendment entry In force
2 Sep 2023
 PDF
Ä 50235795
28 Aug 2023
 First entry In force
28 Aug 2023
 PDF

Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data